Outcomes of infants born to mothers receiving methadone for pain management in pregnancy

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 89, Issue 1, 2004, Pages

  Sharpe, C ^a   Kuschel, C ^a  

^a NATIONAL WOMEN S HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DICLOFENAC; METHADONE; MEXILETINE; MORPHINE; ORPHENADRINE; PARACETAMOL; PETHIDINE;

ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EXPOSURE; DRUG SAFETY; FEEDING DISORDER; FEMALE; HEAD CIRCUMFERENCE; HUMAN; JAUNDICE; LOW DRUG DOSE; MATERNAL PAIN; NEWBORN; NEWBORN MORBIDITY; OPIATE ADDICTION; PAIN; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SIDE EFFECT; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 1642492976     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.89.1.f33     Document Type: Article

References (16)

1. Coles CD, Platzman KA. Behavioral development in children prenatally exposed to drugs and alcohol. Int J Addict 1993;28:1393-433.
2. Behnke M, Eyler FD. The consequences of prenatal substance use for the developing fetus, newborn, and young child. Int J Addict 1993;28:1341-91.
3. Doberczak TM, Thornton JC, Bernstein J, et al. Impact of maternal drug dependency on birth weight and head circumference of offspring. American Journal of Diseases in Children 1987;141:1163-7.
4. Lifschitz MH, Wilson GS, O'Brian Smith E, et al. Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 1985;75:269-74.
5. Soepatmi S. Developmental outcomes of children of mothers dependent on heroin or heroin/methadone during pregnancy. Acta Paediatr 1994;(suppl 404):36-9.
6. Van Baar AL, Soepatmi S, Gunning WB, et al. Development after prenatal exposure to cocaine, heroin and methadone. Acta Paediatr 1994;(suppl 404):40-6.
7. Wouldes TA. Methadone maintenance during pregnancy: the consequences of low dose vs. high dose for the foetus, the neonate and the infant. PhD thesis. University of Auckland, 2001.
8. Zuckerman B, Bresnahan K. Development and behavioural consequences of prenatal drug and alcohol exposure. Pediatr Clin North Am 1991;38:1387-406.
9. Roche S, Hughes EW. Pain problems associated with pregnancy and their management. Pain Reviews 1999;6:239-61.
10. Finnegan LP. Neonatal abstinence syndrome: assessment and pharmacotherapy. In: Rubaltelli FF, e, eds. Neonatal therapy: an update. New York: Elsevier Science Publishers, 1986:122-46.
11. Beeby PJ, Bhuta T, Taylor LK. New South Wales population-based birthweight percentile charts. J Paediatr Child Health 1996;32:512-18.
12. Ward J, Mattick RP, Hall W. Methadone maintenance during pregnancy. In: Ward J, Mattick RP, Hall W, eds. Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood Academic, 1998:397-417.
13. Suffet F, Brotman R. A comprehensive care program for pregnant addicts: obstetrical, neonatal and child development outcomes. Int J Addict 1984;19:199-219.
14. Mack G, Thomas D, Giles W, et al. Methadone levels and neonatal withdrawal. J. Paediatr Child Health 1991;27:96-100.
15. Doberczak TM, Kandall SR, Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 1991;118:933-7.
16. Jacobson B, Nyberg K, Gronbladh L, et al. Opiate addiction in adult offspring through possible imprinting after obstetric treatment. BMJ 1990;301:1067-70.